ABL appoints Stéphanie Colloud as general manager and chief operating officer to lead European activities

ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development and manufacturing of solutions fo...

March 27, 2023 | Monday | News
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and acc...

March 26, 2023 | Sunday | News
Commercial Supply Agreement Signed for Naloxone Nasal Spray to Reverse Opioid Overdoses

Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone a...

March 26, 2023 | Sunday | News
DM Clinical Research Seeks Children for Multiple Studies Including COVID-19 and Migraine

"There are many reasons parents elect to enroll children in clinical trials including access to vaccines that are not yet available to the general public, ...

March 26, 2023 | Sunday | News
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

"The FDA's accelerated approval program has provided patients with cancer earlier access to novel treatments that can be practice changing," said Richard P...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close